Nuclear magnetic resonance spectroscopy: A non-invasive probe of kidney metabolism and function

Experimental Nephrology

Volumn 6, Issue 5, 1998, Pages 409-414

  Foxall, Peta J D ^a   Nicholson, Jeremy K ^b  

^a INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cytoprotection; Fetal kidney; Nephrotoxins; Nuclear magnetic resonance; Osmolytes; Urinalysis

Indexed keywords

ALANINE; ARGININE; CITRIC ACID; FUMARIC ACID; GLUCOSE ALPHA1; GLUTAMINE; HIPPURIC ACID; HISTIDINE; LACTIC ACID; LYSINE; TYROSINE; UNCLASSIFIED DRUG; VALINE;

CELL POLARITY; ENERGY METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR TRANSPORT; KIDNEY FUNCTION; KIDNEY MEDULLA; KIDNEY METABOLISM; KIDNEY POLYCYSTIC DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW;

EID: 0031658655     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020549     Document Type: Review

References (38)

1. Ross B, Freeman D, Chan L: Contributions of nuclear magnetic resonance to renal biochemistry. Kidney Int 1986;29:131-141.
2. Videen JS, Ross BD: Proton nuclear magnetic resonance urinalysis: Coming of age. Kidney Int 1994;46(suppl):122-128.
3. Neild GH, Foxall PJD, Lindon JC, Holmes E, Nicholson JK: Uroscopy in the 21st century: High field NMR spectroscopy. Nephrol Dial Transplant 1997;12:404-417.
4. Nicholson JK, Wilson ID: High resolution proton magnetic resonance spectroscopy of biological fluids. Prog NMR Spectrosc 1989;21:449-501.
5. Sanders JKM, Hunter BK: Modern NMR Spectroscopy: A Guide for Chemists, ed 2. Oxford, Oxford University Press, 1993.
6. Lindon JC, Nicholson JK: Recent advances in high-resolution NMR spectroscopic methods in bioanalytical chemistry. Trends Anal Chem 1997;16:190-200.
7. Somero GN: Protons, osmolytes, and fitness of internal milieu for protein function. Am J Physiol 1986;251:R197-R213.
8. Balaban RS, Burg MB: Osmotically active organic solutes in the renal inner medulla. Kidney Int 1987;31:562-564.
9. 2H NMR spectroscopic studies of the metabolism and biochemical effects of 2-bromoethanamine in the rat. Biochem Pharmacol 1995;49:1349-1359.
10. Foxall PJD, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK: NMR spectroscopy as a novel approach to monitor renal transplant function. Kidney Int 1993;43:234-245.
11. Le Moyec L, Pruna A, Eugene M, Bedrossian J, Idatte JM, Huneau JF, Tome D: Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 1993;65:433-439.
12. Bell JD, Lee JA, Lee HA, Sadler PJ, Wilkie DR, Woodham RH: Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: Identification of trimethylamine-N-oxide. Biochim Biophys Acta 1991;1096:101-107.
13. Foxall PJD, Bewley S, Neild GH, Rodeck CH, Nicholson JK: Analysis of neonatal and fetal urine using proton nuclear magnetic resonance spectroscopy Arch Dis Child 1995;73:F153-F157.
14. Davies SEC, Woolf DA, Chalmers RA, Rafter JEM, Iles RA: Proton NMR studies of betaine excretion in the human neonate: Consequences for choline and methyl-group supply. J Nutr Biochem 1992;3:523-530.
15. Foxall PJD, Price RG, Jones JK, Neild GH, Thompson FD, Nicholson JK; High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochim Biophys Acta 1992;1138:305-314.
16. Ogborn MR, Sareen S, Prychitco J, Buist R, Peeling J: Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: An NMR study. Am J Physiol 1997;41:F63-F69.
17. Eugene M, Muller F, Dommergues M, Le Moyec L, Dumez Y: Evaluation of postnatal renal function in fetuses with bilateral obstructive nephropathies by proton nuclear magnetic resonance spectroscopy. Am J Obstet Gynecol 1994;170:595-602.
18. 13C-NMR investigation of the metabolism of amino acids in renal proximal convoluted tubules of normal and streptozotocin-treated rats and rabbits. Biochem J 1989;263:231-241.
19. Endre ZH, Kuchel PW: Proton NMR spectroscopy of rabbit renal cortex. Kidney Int 1985;28:6-10.
20. Cianbilla FG, Pincemail JF, Defraigne JO, Franssen CL, Carlier PG: The effect of technical conditions and storage medium composition on the phosphomonoesters to inorganic phosphate ratio determined by P-31 nuclear magnetic resonance spectroscopy in rabbit kidney. Transplantation 1993;56:696-699.
21. Martin G, Chauvin MF, Bavarel G: Model applicable to NMR studies for calculating flux rates in five cycles involved in glutamate metabolism. J Biol Chem 1997;272:4717-4728.
22. Kinne RKH, Grunewald RW, Ruhfus B, Kinne-Saffran E: Biochemistry and physiology of carbohydrates in the renal collecting duct. J Exp Zool 1997;279:436-442.
23. 1H NMR analysis of intact prostatic hyperplastic and tumour tissues. Anal Commun, in press, 1998.
24. Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem 1984;30:426-432.
25. Iles RA, Chalmers RA: Nuclear magnetic resonance spectroscopy in the study of inborn errors of metabolism. Clin Sci 1988;74:1-10.
26. Foxall PJD, Singer JM, Hartley JM, Neild GH, Nicholson JK, Souhami RL Proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity in patients with and without encephalopathy. Clin Cancer Res 1997;3:1507-1518.
27. Gartland KPR, Bonner FW, Nicholson JK: Investigations into the biochemical effects of region-specific nephrotoxins. Mol Pharmacol 1989;35:242-250.
28. 1H NMR spectroscopic studies on the characterisation of renal cell lines and identification of novel potential markers of in vitro nephrotoxicity. Biomarkers 1996;1:35-43.
29. Halligan S, Byard SJ, Spencer AJ, Gray TJB, Harpur ES, Bonner FW: A study of the nephrotoxicity of 3 cephalosporins in rabbits using H-1-NMR spectroscopy. Toxicol Lett 1995;81:15-21.
30. Anthony ML, Gartland KPR, Beddell CR, Lindon JR, Nicholson JK: Studies of the biochemical toxicology of uranyl nitrate. Arch Toxicol 1994;69:43-53.
31. Gartland KPR, Beddell CR, Lindon JC, Nicholson JK: Application of pattern recognition methods to the analysis and classification of lexicological data derived from the proton nuclear magnetic resonance spectroscopy of urine. Mol Pharmacol 1991;39:629-642.
32. Anthony ML, Sweatman BC, Beddell CR, Lindon JC, Nicholson JK: Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. Mol Pharmacol 1994;46:199-211.
33. Foxall PJD, Bending MR, Gartland KPR, Nicholson JK: Acute renal failure following accidental cutaneous absorption of phenol: Application of NMR urinalysis to monitor the disease process. Hum Toxicol 1989;9:491-496.
34. 31P nuclear magnetic resonance spectroscopy. J Pharmacol Exp Ther 1992;260:1133-1144.
35. Foxall PJD, Lenz EM, Lindon JC, Neild GH, Wilson ID, Nicholson JK: NMR and HPLC-NMR studies on the toxicity and metabolism of ifosfamide. Ther Drug Monit 1996;18:51-58.
36. Weinburg JM, Venkatachalam MA, GarzaQuintero R, Roeser NF, Davis JA: Structural requirements for protection by small amino acids against hypoxic injury in kidney proximal tubules. FASEB J 1990;4:3347-3354.
37. Nissim I, Weinberg JM: Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats. Kidney Int 1996;49:684-695.
38. Kitamura H, Yamauchi A, Sugiura T, Matsuoka Y, Mono M, et al: Inhibition of myo-inositol transport causes acute renal failure with selective medullary injury in the rat. Kidney Int 1998;53:146-153.